Feldman AM, Mann DL, She L, Bristow MR, Maisel AS, McNamara DM et al. Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials. Circulation: Heart Failure. 2013; 6(3):461-72 116. Felker GM, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N et al. Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: A randomized clinical trial. JAMA. 117. Field K, Ziebland S, McPherson A, Lehman R. 'Can I come off the tablets now?'A qualitative analysis of heart failure patients' understanding of their medication. Family Practice. 2006; 118. Filippatos G, Farmakis D, Colet JC, Dickstein K, Luscher TF, Willenheimer R et al. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. European Journal of Heart Failure. 2013; 119. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). European Heart Journal. 120. Fluur C, Bolse K, Str mberg A, Thyl n I. Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues. Heart and 121. Fluur C, Bolse K, Str mberg A, Thyl n I. Spouses' reflections on implantable cardioverter defibrillator treatment with focus on the future and the end-of-life: a qualitative content analysis. Journal of Advanced Nursing. 2014; 70(8):1758-1769 122. Frankenstein L, Goode K, Ingle L, Remppis A, Schellberg D, Nelles M et al. 